Basit öğe kaydını göster

dc.contributor.authorSoyluk, O.
dc.contributor.authorSelcukbiricik, F.
dc.contributor.authorKapran, Y.
dc.contributor.authorBozbora, A.
dc.contributor.authorOzbey, N.
dc.contributor.authorErbil, Y.
dc.date.accessioned2021-03-03T13:00:05Z
dc.date.available2021-03-03T13:00:05Z
dc.date.issued2008
dc.identifier.citationSoyluk O., Selcukbiricik F., Erbil Y., Bozbora A., Kapran Y., Ozbey N., "Prognostic factors in patients with papillary thyroid carcinoma", JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, cilt.31, sa.11, ss.1032-1037, 2008
dc.identifier.issn1720-8386
dc.identifier.othervv_1032021
dc.identifier.otherav_315c1846-e1a3-482a-8acd-2a99ce428071
dc.identifier.urihttp://hdl.handle.net/20.500.12627/37598
dc.identifier.urihttps://doi.org/10.1007/bf03345644
dc.description.abstractBackground: Papillary thyroid carcinomas are associated with metastases and decreased survival in a small group of patients. Aim: The aim of this study is to determine the factors associated with recurrences/metastases in papillary thyroid carcinoma patients. Subjects and methods: One hundred and thirty-one patients with papillary thyroid carcinoma were evaluated retrospectively. The diagnosis was papillary microcarcinoma (PMC) in 48 patients. All patients had undergone near-total/total thyroidectomy. Radioactive iodine was given to 103 patients. Age at diagnosis, gender, previous history of thyroid disease, tumor stage, histopathological characteristics of tumor and initial treatment strategies were evaluated. Results: Recurrences/metastases developed in 17 patients during follow-up. Recurrences developed at a significantly higher percentage in patients with a tumor stage >T1 and patients with lymph node metastasis at presentation. No significant difference was observed in recurrence ratio between patients with PMC and patients with a tumor diameter 21 cm. In the Cox-regression analysis only the advanced tumor stage (>T1) and presence of lymph node metastases were found to be significant predictors for recurrence (univariate analysis, odds ratio =4.02 and 3.15, respectively). However, multivariate analysis did not reveal any significant independent predictors. According to the Kaplan-Meier survival analysis, lymph node metastases at presentation were associated with a decrease in recurrence-free survival at statistical significance (p=0.05). No mortality was observed during follow-up. Conclusion: Papillary thyroid carcinoma leads to recurrences/metastases in a small group of patients. Initial characteristics of the patients - i.e. presence of lymph node metastases - may predict recurrences/metastases in these patients. (J. Endocrinol. Invest. 31: 1032-1037, 2008) (C) 2008, Editrice Kurtis
dc.language.isoeng
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.titlePrognostic factors in patients with papillary thyroid carcinoma
dc.typeMakale
dc.relation.journalJOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
dc.contributor.department, ,
dc.identifier.volume31
dc.identifier.issue11
dc.identifier.startpage1032
dc.identifier.endpage1037
dc.contributor.firstauthorID190006


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster